We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Biotech Growth Trust (the) Plc | LSE:BIOG | London | Ordinary Share | GB0000385517 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-21.00 | -2.32% | 885.00 | 880.00 | 883.00 | 901.00 | 880.00 | 901.00 | 76,716 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 80.35M | 74.6M | 2.3339 | 3.77 | 289.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/1/2020 09:56 | Discount seems far too large, my thinking is at somepoint investor desire for the fangs will weaken and biotechs with new new breakthroughs underpinned by ever increasing demand from ageing populations etc could easily take over. Not a bad area to have some exposure to regardless. | its the oxman | |
01/8/2019 15:04 | That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance. | healthtech | |
29/7/2019 15:56 | IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point | rogerrail | |
04/7/2019 08:06 | Oxman , appears you were right. | the oak tree | |
01/11/2018 13:52 | Good time to buy sub 700p ? | its the oxman | |
04/4/2018 09:33 | Or maybe the funds management are too busy sipping champagne on our money to notice the money we trusted them with is evaporating. | andyj | |
03/4/2018 23:56 | Share price nearly 10% below NAV now, should see some buy backs. | andyj | |
28/3/2018 16:06 | I will settle for getting my money back | andyj | |
28/3/2018 07:06 | Will be £10+ before years out.. | losses | |
26/3/2018 13:45 | 9% drop in the NAV last week. | andyj | |
28/2/2018 14:08 | By the way, there is an excellent and insightful free research paper on BIOG at Edison Investment Research dated Feb 22. Sorry I cannot post the link. | andyj | |
28/2/2018 13:48 | Thanks all, probably sound advice, just having a clear out of underperforming investments in my portfolio and noticed BIOG has consistently been a losing investment for me. | andyj | |
28/2/2018 13:21 | For me I'm in as it broadens my spread and exposure. But I also get into something that in the long term should imho do well. I believe we'll make the same stride in bio than we have made in technologies e.g google maps, smart phones etc we have had. Agree though don't like spikes but in the long term not an issue. I also don't care about the discount as that will come back with performance. | the oak tree | |
28/2/2018 11:59 | I agree. good safe long term hold. | shaker44 | |
28/2/2018 11:21 | This one is not for trading Andy.. but and forget... couple years down the road it will double... | losses | |
28/2/2018 11:09 | I have had enough of this fund. The discount is widening, the spread is often ridiculously wide and the way it has spiked up in recent years concerns me. I will try to get my money back. | andyj | |
02/1/2018 14:14 | Was expecting this to follow net asset value which is way above 800.. | losses | |
06/12/2017 22:05 | I was wondering why this started dropping... hopefully get back on the up soon. | losses | |
21/11/2017 06:13 | I agree, huge potential in biotech and rather those with expertise choose the companies to invest in than me. 2% discount to NAV, I I am in. | andyj | |
19/11/2017 22:20 | Bought in here on Friday so keen on others views. Its had a good run though and little if any discount. Its part of a balanced portfolio but feel its a merited position due to this sector perhaps going through what technology has done this last 20 years. Bio science will have its iPhone / google maps moment as some point in the next 10-20 years I reckon. IMHO | the oak tree | |
22/6/2017 04:28 | https://seekingalpha | hutch_pod | |
01/3/2017 11:05 | Yeah. Good luck. Personally I believe markets to be more event driven.e.g. geo-political, and trumps income/spending mismatch.And attack on healthcare. So I am more likely a seller at this level whatever charts may indicate... | shaker44 | |
01/3/2017 10:18 | This stuff works for me and I'm not leveraged. I use TA on all assets to establish entries targets and exits. We've been stuck at this 740-760 resistance for some months(which coincidentally is the 61.8% retracement of the July 2015 - Jun 2016 correction therefore its likely others also apply TA to this fund). If we can clear sellers from this level and break above this resistance (which we're currently trying to do) it should become a good level of support in the future and an area I will use to add to my current position with a medium term target of 970-1000p. Each to their own ;-) | powersno1 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions